News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year – Paolo Tarantino
Photo from Paolo Tarantino/Twitter
Aug 6, 2023, 17:11

Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year – Paolo Tarantino

With ESMO23 and SABCS23 approaching, we may soon see the results from several potentially practice-changing trials in breast oncology. Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year.Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year - Paolo Tarantino

Source: Paolo Tarantino / Twitter

breast oncology cancer clinical trials ESMO23 OncoDaily Oncology Paolo Tarantino
Special Coverage
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO
Science
Dec 24, 2024, 23:36
Drew Moghanaki: An updated report from the MISSILE study team
Science
Dec 24, 2024, 23:31
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
Insight
Dec 24, 2024, 23:29
Mark Bolton: What if patients switch treatment at progression
Blog
Dec 24, 2024, 23:27
Give the gift of hope, brighter futures, and more time for patients and families - The Leukemia And Lymphoma Society
Blog
Dec 24, 2024, 23:24
Shaban Juma: Community health education is the key component in disease prevention
Blog
Dec 24, 2024, 23:21
Christos Tsagkaris: Delivering a talk about secondary research at Attikon University Hospital
Blog
Dec 24, 2024, 23:17
Senator Tim Kaine honors Gabriella Miller's legacy in pediatric cancer research
Insight
Dec 24, 2024, 18:19
ICR’s spinout company “Sentinal4D” has officially been launched
Blog
Dec 24, 2024, 18:16
Ronit Satchi-Fainaro: Target Therapies in P-selectin-expressing cancers
Blog
Dec 24, 2024, 18:11
Bishal Gyawali: Are U.S. patients paying twice for cancer drugs?